GAMMA Investing »

Ligand Pharmaceuticals In shares owned by GAMMA Investing

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $12k 161 73.10
2023-12-31 $17k 229 73.02

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Ligand Pharmaceuticals In

Vanguard Group
Henderson Group
Dimensional Fund Advisors
St. Denis J. Villere & Co
Pacer Advisors
Standard Life Aberdeen
Rice Hall James & Associates
Chicago Capital
Impax Asset Management Group
William Blair Investment Management
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of New York Mellon
Man Group
Kornitzer Capital Management

View all funds holding Ligand Pharmaceuticals In